Payami, Babak, Afshin Zarrin, Mofid Hosseinzadeh, Habib Haybar, and Sepideh Khodamoradi. 2023. “Amiodarone Can Still Be a Drug of Choice at Emergency Departments for Pre-Excited Atrial Fibrillation Even in the Face of Guidelines Prohibition”. Iranian Journal of Emergency Medicine 10 (1):e8. https://doi.org/10.22037/ijem.v10i1.40732.